Sold out
Vichy Normaderm Anti-blemish Corrective Care Cream for Oily/Acne Skin with Salicylic Acid – 50ml
US$25.00
A Correcting Anti-Blemish Care Moisturiser targets concerns and provided 24 hour hydration.
The blemish control moisturiser is enriched with an ultra-light substance called Airlicium, an innovation that works to disperse and absorb sebum. Combined with mattifying ingredients it gives skin a soft focus effect whilst reducing the appearance of pores. The formula also contains LHA: Salicylic Acid (1.5%), which targets oily skin and helps the skin look radiant and beautiful.
Add US$30.00 to cart and get free shipping!
Out of stock
Want to be notified when this product is back in stock?
EAN: 3337875414111
SKU:
VCY009
Categories: Acne, Brand, Care Type, Combination Skin, Cream, dark spots, Day, Face care, Hydration, Large Pores, Light, Loss Of Radiance, Men, Oil Control, Oily Skin, Salicylic Acid, Skin Care, Vichy, Women
Tag: Blemish _Acne-Free_Skin_Gifts
Description
Description
A Correcting Anti-Blemish Care Moisturiser targets concerns and provided 24 hour hydration.
Key Benefits:
1- Combats signs of imperfection-prone skin and immediately starts working to clear concerns, including hormonal blemishes
2- Skin looks radiant, hydrated and beautiful
3- Light texture, non-greasy and non-sticky
4- Ideal make-up base
5- Provides up to 24 hours hydration
Suitable for sensitive skin
Tested on sensitive skin under dermatological control
Hypoallergenic
Key Ingredients:
1- Salicylic Acid (1.5%): targets oily skin and helps the skin look radiant and beautiful.
2- Vichy Mineralizing Water
3- Airlicium
How to Use:
Use Normaderm Correcting Anti-Blemish Care Moisturiser morning or evening to moisturise the face after Minéral 89.
Visible Results:
Leaves skin feeling mattified, comfortable and hydrated for 24 hours.
Reviews (0)
Be the first to review “Vichy Normaderm Anti-blemish Corrective Care Cream for Oily/Acne Skin with Salicylic Acid – 50ml” Cancel reply
You must be logged in to post a review.
Reviews
There are no reviews yet.